2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis

被引:15
作者
Iihara, Hirotoshi [1 ]
Abe, Masakazu [2 ]
Wada, Makoto [3 ]
Iino, Keiko [4 ]
Akechi, Tatsuo [5 ]
Imamura, Chiyo K. [6 ]
Okuyama, Ayako [7 ]
Ozawa, Keiko [8 ]
Kim, Yong-Il [9 ]
Sasaki, Hidenori [10 ]
Satomi, Eriko [11 ]
Takeda, Masayuki [12 ]
Tanaka, Ryuhei [13 ]
Nakajima, Takako Eguchi [14 ]
Nakamura, Naoki [15 ]
Nishimura, Junichi [16 ]
Noda, Mayumi [17 ]
Hayashi, Kazumi [18 ]
Higashi, Takahiro [19 ]
Boku, Narikazu [20 ]
Matsumoto, Koji [21 ]
Matsumoto, Yoko [22 ]
Okita, Kenji [23 ]
Yamamoto, Nobuyuki [24 ]
Aogi, Kenjiro [25 ]
机构
[1] Gifu Univ Hosp, Dept Pharm, 1-1 Yanagido, Gifu 5011194, Japan
[2] Hamamatsu Univ, Sch Med, Dept Obstet & Gynecol, 1-20-1 Handayama,Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan
[3] Osaka Int Canc Inst, Dept Psychooncol & Palliat Med, 3-1-69,Otemae,Chuo Ku, Osaka, Osaka 5418567, Japan
[4] Natl Coll Nursing, Sch Nursing, 1-2-1 Umezono, Kiyose, Tokyo 2048575, Japan
[5] Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, 1 Kawasumi,Mizuho-Cho,Mizuho Ku, Nagoya 4678601, Japan
[6] Showa Univ, Adv Canc Translat Res Inst, 1-5-8 Hatanodai,Shinagawa Ku, Tokyo 1428555, Japan
[7] St Lukes Int Univ, Grad Sch Nursing Sci, 10-1 Akashi Cho,Chuo Ku, Tokyo 1040044, Japan
[8] Natl Canc Ctr, Inst Canc Control, Div Survivorship, 5-1-1 Tsukiji,Chuo Ku, Tokyo 1040045, Japan
[9] Yodogawa Christians Hosp, Div Med Oncol, 1-7-50 Kunijima,Higasiyodogawa Ku, Osaka, Osaka 5330024, Japan
[10] Fukuoka Univ Hosp, Div Med Oncol Hematol & Infect Dis, 7-45-1 Nanakuma,Jonan Ku, Fukuoka 8140180, Japan
[11] Natl Canc Ctr, Dept Palliat Med, 5-1-1 Tsukiji,Chuo Ku, Tokyo 1040045, Japan
[12] Nara Med Univ, Dept Canc Genom & Med Oncol, Sch Med, 840 Shijo Cho, Kashihara, Nara 6348521, Japan
[13] Saitama Med Univ, Int Med Ctr, Dept Pediat Hematol Oncol, 1398-1 Yamane, Hidaka, Saitama 3501298, Japan
[14] Kyoto Univ, Grad Sch Med, Dept Early Clin Dev, 54 Kawahara Cho,Sakyo Ku, Shogoin, Kyoto 6068507, Japan
[15] St Marianna Univ, Dept Radiat Oncol, 2-16-1 Sugao,Miyamae, Kawasaki, Kanagawa 2168511, Japan
[16] Osaka Int Canc Inst, Dept Gastroenterol Surg, 3-1-69 Otemae,Chuo Ku, Osaka 5418567, Japan
[17] Nonprofit Org Sasaeau Kai Alpha, 518-7 Kawado Cho,Chuo Ku, Chiba 2600802, Japan
[18] Jikei Univ, Sch Med, Dept Clin Oncol & Hematol, 3-25-8 Nishi-Shinnbashi Minatoku, Tokyo 1058461, Japan
[19] Univ Tokyo, Dept Publ Hlth & Hlth Policy, 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan
[20] Univ Tokyo, IMSUT Hosp, Inst Med Sci, Dept Oncol & Gen Med, 4-6-1 Shiroganedai,Minato Ku, Tokyo 1088639, Japan
[21] Hyogo Canc Ctr, Div Med Oncol, 13-70 Kitaoji Cho, Akashi, Hyogo 6730021, Japan
[22] Nonprofit Org Ehime Canc Support Orange No Kai, 3-8-24 Furukawaminami, Matsuyama, Ehime 7900943, Japan
[23] Otaru Ekisaikai Hosp, Dept Surg, 1-4-1 Inaho, Otaru, Hokkaido 0470032, Japan
[24] Wakayama Med Univ, Internal Med 3, 811-1 Kimiidera, Wakayama 6418509, Japan
[25] Natl Hosp Org Shikoku Canc Ctr, Dept Breast Surg, 160 Kou,Minamiumemoto Machi, Matsuyama, Ehime 7910280, Japan
关键词
Antiemesis; Nausea; Vomiting; CINV; Cancer chemotherapy; Clinical practice guidelines;
D O I
10.1007/s10147-024-02535-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis 2023 was extensively revised to reflect the latest advances in antineoplastic agents, antiemetics, and antineoplastic regimens. This update provides new evidence on the efficacy of antiemetic regimens.Methods Guided by the Minds Clinical Practice Guideline Development Manual of 2017, a rigorous approach was used to update the guidelines; a thorough literature search was conducted from January 1, 1990, to December 31, 2020.Results Comprehensive process resulted in the creation of 13 background questions (BQs), 12 clinical questions (CQs), and three future research questions (FQs). Moreover, the emetic risk classification was also updated.Conclusions The primary goal of the present guidelines is to provide comprehensive information and facilitate informed decision-making, regarding antiemetic therapy, for both patients and healthcare providers.
引用
收藏
页码:873 / 888
页数:16
相关论文
共 5 条
[1]  
[Anonymous], 2017, Minds Clinical Practice Guideline Development Manual
[2]   Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015 Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis [J].
Aogi, Kenjiro ;
Takeuchi, Hideki ;
Saeki, Toshiaki ;
Aiba, Keisuke ;
Tamura, Kazuo ;
Iino, Keiko ;
Imamura, Chiyo K. ;
Okita, Kenji ;
Kagami, Yoshikazu ;
Tanaka, Ryuhei ;
Nakagawa, Kazuhiko ;
Fujii, Hirofumi ;
Boku, Narikazu ;
Wada, Makoto ;
Akechi, Tatsuo ;
Iihara, Hirotoshi ;
Ohtani, Shoichiro ;
Okuyama, Ayako ;
Ozawa, Keiko ;
Kim, Yong-Il ;
Sasaki, Hidenori ;
Shima, Yasuo ;
Takeda, Masayuki ;
Nagasaki, Eijiro ;
Nishidate, Toshihiko ;
Higashi, Takahiro ;
Hirata, Kouichi .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (01) :1-17
[3]   Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive [J].
Jaeschke, Roman ;
Guyatt, Gordon H. ;
Dellinger, Phil ;
Schunemann, Holger ;
Levy, Mitchell M. ;
Kunz, Regina ;
Norris, Susan ;
Bion, Julian .
BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 (7665) :a744
[4]  
Japan Society of Clinical Oncology, Clinical practice guidelines for antiemesis
[5]   Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary [J].
Takeuchi, Hideki ;
Saeki, Toshiaki ;
Aiba, Keisuke ;
Tamura, Kazuo ;
Aogi, Kenjiro ;
Eguchi, Kenji ;
Okita, Kenji ;
Kagami, Yoshikazu ;
Tanaka, Ryuhei ;
Nakagawa, Kazuhiko ;
Fujii, Hirofumi ;
Boku, Narikazu ;
Wada, Makoto ;
Akechi, Tatsuo ;
Udagawa, Yasuhiro ;
Okawa, Yutaka ;
Onozawa, Yusuke ;
Sasaki, Hidenori ;
Shima, Yasuo ;
Shimoyama, Naohito ;
Takeda, Masayuki ;
Nishidate, Toshihiko ;
Yamamoto, Akifumi ;
Ikeda, Tadashi ;
Hirata, Koichi .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (01) :1-12